IL-1 family cytokines in inflammation and immunity

Cellular and Molecular Immunology · Published 2025-10-14 · DOI 10.1038/s41423-025-01358-8

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s41423-025-01358-8

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Inflammation-driven multiorgan Dysfunction: Biomarker-Guided diagnosis, mechanistic insights and emerging precision therapeutic strategies · Advances in Biomarker Sciences and Technology · 2026 · Cites or is cited by this article
• Programmed cell death in autoimmune diseases · Autoimmunity Reviews · 2026 · Cites or is cited by this article
• Phenotypic and functional changes to porcine monocyte-derived macrophages triggered by IL-1β and its receptor antagonist IL-1Ra · Frontiers in Immunology · 2026 · Cites or is cited by this article
• Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics · Cancer Biology and Therapy · 2026 · Cites or is cited by this article
• IL-1β signaling as a molecular arbiter of stem cell plasticity: orchestrating the niches of repair, fibrosis, and cancer · Seminars in Immunology · 2026 · Cites or is cited by this article
• A novel cyprinid-specific IL-1 family cytokine activates inflammatory responses · Developmental and Comparative Immunology · 2026 · Cites or is cited by this article
• Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis · Cellular and Molecular Immunology · 2026 · Same journal
• Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation · Cellular and Molecular Immunology · 2026 · Same journal
• Melanosomes support immune evasion in melanoma · Cellular and Molecular Immunology · 2026 · Same journal
• T cell adaptation in chronic infections and tumors · Cellular and Molecular Immunology · 2026 · Same journal